Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Auger

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Plos One|August 1, 2015
Antinuclear Antibodies in Patients with Psoriatic Arthritis Treated or Not with BiologicsFlorent Silvy, Daniel Bertin, Nathalie Bardin, et al.
Joint Bone Spine|December 14, 2004
Clinical and pathophysiological significance of the autoimmune response to citrullinated proteins in rheumatoid arthritisMireille Sebbag, Sabine Chapuy-Regaud, Isabelle Auger, et al.
Plos One|February 16, 2017
Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective studyNathalie Balandraud, Gaetan Texier, Emmanuel Massy, et al.
Frontiers in Immunology|July 12, 2021
In Rheumatoid Arthritis Patients, HLA-DRB1*04:01 and Rheumatoid Nodules Are Associated With ACPA to a Particular Fibrin EpitopeGuillaume Larid, Mikael Pancarte, Géraldine Offer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 11, 2019
Peptidylarginine Deiminase Autoimmunity and the Development of Anti-Citrullinated Protein Antibody in Rheumatoid Arthritis: The Hapten-Carrier ModelIsabelle Auger, Nathalie Balandraud, Emmanuel Massy, et al.
Plos One|June 6, 2013
HLA-DRB1 genotypes and the risk of developing anti citrullinated protein antibody (ACPA) positive rheumatoid arthritisNathalie Balandraud, Christophe Picard, Denis Reviron, et al.
BMC Family Practice|June 21, 2013
How French physicians manage with a future change in the primary vaccination of infants against diphtheria, tetanus, pertussis and poliomyelitis? A qualitative study with focus groupsKarine Lungarde, Fanette Blaizeau, Isabelle Auger-Aubin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 24, 2025
A tolerogenic plasmid inhibits autoantibody production triggered by immunization with human peptidyl arginine deiminase 4Philippe P Pagni, Vijetha Kumar, Nathalie C Lambert, et al.
Arthritis and Rheumatism|December 1, 2007
Influence of -308 A/G polymorphism in the tumor necrosis factor alpha gene on etanercept treatment in rheumatoid arthritisSandrine Guis, Nathalie Balandraud, Julien Bouvenot, et al.
Plos One|June 30, 2016
Evaluation of X Chromosome Inactivation with Respect to HLA Genetic Susceptibility in Rheumatoid Arthritis and Systemic SclerosisSami B Kanaan, Onur E Onat, Nathalie Balandraud, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Plos One|August 1, 2015
Antinuclear Antibodies in Patients with Psoriatic Arthritis Treated or Not with BiologicsFlorent Silvy, Daniel Bertin, Nathalie Bardin, et al.
Joint Bone Spine|December 14, 2004
Clinical and pathophysiological significance of the autoimmune response to citrullinated proteins in rheumatoid arthritisMireille Sebbag, Sabine Chapuy-Regaud, Isabelle Auger, et al.
Plos One|February 16, 2017
Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective studyNathalie Balandraud, Gaetan Texier, Emmanuel Massy, et al.
Frontiers in Immunology|July 12, 2021
In Rheumatoid Arthritis Patients, HLA-DRB1*04:01 and Rheumatoid Nodules Are Associated With ACPA to a Particular Fibrin EpitopeGuillaume Larid, Mikael Pancarte, Géraldine Offer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 11, 2019
Peptidylarginine Deiminase Autoimmunity and the Development of Anti-Citrullinated Protein Antibody in Rheumatoid Arthritis: The Hapten-Carrier ModelIsabelle Auger, Nathalie Balandraud, Emmanuel Massy, et al.
Plos One|June 6, 2013
HLA-DRB1 genotypes and the risk of developing anti citrullinated protein antibody (ACPA) positive rheumatoid arthritisNathalie Balandraud, Christophe Picard, Denis Reviron, et al.
BMC Family Practice|June 21, 2013
How French physicians manage with a future change in the primary vaccination of infants against diphtheria, tetanus, pertussis and poliomyelitis? A qualitative study with focus groupsKarine Lungarde, Fanette Blaizeau, Isabelle Auger-Aubin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 24, 2025
A tolerogenic plasmid inhibits autoantibody production triggered by immunization with human peptidyl arginine deiminase 4Philippe P Pagni, Vijetha Kumar, Nathalie C Lambert, et al.
Arthritis and Rheumatism|December 1, 2007
Influence of -308 A/G polymorphism in the tumor necrosis factor alpha gene on etanercept treatment in rheumatoid arthritisSandrine Guis, Nathalie Balandraud, Julien Bouvenot, et al.
Plos One|June 30, 2016
Evaluation of X Chromosome Inactivation with Respect to HLA Genetic Susceptibility in Rheumatoid Arthritis and Systemic SclerosisSami B Kanaan, Onur E Onat, Nathalie Balandraud, et al.
Pageof 6